Interestingly, MAP2 protein levels at 30 days were significantly decreased in the cerebellum of AMS mice compared to those of wild-type or Nna1 mutation heterozygous mice (Figure 7B,C). The gene discussed is AGTPBP1; the disease is ablepharon macrostomia syndrome.